Go Pro
→ Here’s the stock symbol I’ve promised (From Stansberry Research) (Ad)tc pixel
OTCMKTS:TRUMY

Terumo Q3 2025 Earnings Report

Terumo logo
$14.78 +0.39 (+2.71%)
As of 03:58 PM Eastern
ProfileEarnings HistoryForecast

Terumo EPS Results

Actual EPS
$0.16
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Terumo Revenue Results

Actual Revenue
$1.73 billion
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Terumo Announcement Details

Quarter
Q3 2025
Date
2/13/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Terumo's next earnings date is estimated for Wednesday, November 11, 2026, based on past reporting schedules.

Conference Call Resources

Terumo Earnings Headlines

Terumo Corp. (OTCMKTS:TRUMY) Short Interest Update
September 27, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31055133
Terumo ADR (TRUMY)
September 5, 2026  |  es.investing.comhttps://es.investing.com/equities/terumo-adr
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.tc pixel
October 1 at 1:00 AM  |  Chaikin Analytics (Ad)
Terumo Corporation (TRUMY) Q1 2027 Earnings Call Prepared Remarks Transcript
August 12, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4935290-terumo-corporation-trumy-q1-2027-earnings-call-prepared-remarks-transcript
Terumo Corporation (TRUMY) Analyst/Investor Day Transcript
June 12, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4914117-terumo-corporation-trumy-analyst-investor-day-transcript
Terumo ADR Stock Price History
May 17, 2026  |  investing.comhttps://www.investing.com/equities/terumo-adr-historical-data
See More Terumo Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Terumo? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Terumo and other key companies, straight to your email.

About Terumo

Terumo (OTCMKTS:TRUMY) Corporation is a Japan-based medical technology company that develops, manufactures and sells products used in hospitals, clinics and other healthcare settings. Founded in 1921 by a group of Japanese medical doctors, the company initially produced clinical thermometers and has since expanded into a global provider of medical devices and related services.

Terumo’s principal businesses include cardiac and vascular products, blood and cell technologies, and general hospital solutions. Its portfolio includes interventional devices and systems used in cardiovascular procedures, blood collection and processing equipment, transfusion products, infusion and injection devices, and other products designed to support patient care and clinical workflows. The company also provides technologies for diabetes management and other specialized medical applications.

Terumo serves healthcare providers and patients internationally through operations and distribution networks spanning Japan, the Americas, Europe, Asia and other markets. Its products are used across a range of medical specialties, including cardiovascular care, blood management, interventional procedures, infusion therapy and hospital operations.

View Terumo Profile
Earnings Tools